Literature DB >> 21373207

External Quality Assurance in Immunohistochemistry - Is It the Solution to a Complex Problem?

Angelika Reiner-Concin1.   

Abstract

Year:  2008        PMID： 21373207      PMCID： PMC2931078          DOI： 10.1159/000126738

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  8 in total

Review 1.  Effect of formalin tissue fixation and processing on immunohistochemistry.

Authors:  M Werner; A Chott; A Fabiano; H Battifora
Journal:  Am J Surg Pathol       Date:  2000-07       Impact factor: 6.394

2.  Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratories.

Authors:  Peter Regitnig; Angelika Reiner; Hans-Peter Dinges; Gerald Höfler; Elisabeth Müller-Holzner; Sigurd F Lax; Peter Obrist; Margaretha Rudas; Franz Quehenberger
Journal:  Virchows Arch       Date:  2002-09-17       Impact factor: 4.064

3.  Implementation of External Quality Assurance Trials for Immunohistochemically Determined Breast Cancer Biomarkers in Germany.

Authors:  Reinhard von Wasielewski; Claudia A Krusche; Joseph Rüschoff; Anette Fisseler-Eckhoff; Hans Kreipe
Journal:  Breast Care (Basel)       Date:  2008-04-15       Impact factor: 2.860

4.  Monoclonal antibodies to estrophilin: probes for the study of estrogen receptors.

Authors:  G L Greene; F W Fitch; E V Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

Review 5.  Current perspectives on HER2 testing: a review of national testing guidelines.

Authors:  Michael Bilous; Mitch Dowsett; Wedad Hanna; Jorma Isola; Annette Lebeau; Aberlardo Moreno; Frédérique Penault-Llorca; Josef Rüschoff; Gorana Tomasic; Marc van de Vijver
Journal:  Mod Pathol       Date:  2003-02       Impact factor: 7.842

6.  The use of cell line standards to reduce HER-2/neu assay variation in multiple European cancer centers and the potential of automated image analysis to provide for more accurate cut points for predicting clinical response to trastuzumab.

Authors:  Anthony Rhodes; Duncan Borthwick; Rob Sykes; Salam Al-Sam; Angelo Paradiso
Journal:  Am J Clin Pathol       Date:  2004-07       Impact factor: 2.493

7.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; Jared N Schwartz; Karen L Hagerty; D Craig Allred; Richard J Cote; Mitchell Dowsett; Patrick L Fitzgibbons; Wedad M Hanna; Amy Langer; Lisa M McShane; Soonmyung Paik; Mark D Pegram; Edith A Perez; Michael F Press; Anthony Rhodes; Catharine Sturgeon; Sheila E Taube; Raymond Tubbs; Gail H Vance; Marc van de Vijver; Thomas M Wheeler; Daniel F Hayes
Journal:  Arch Pathol Lab Med       Date:  2007       Impact factor: 5.534

8.  Practice of HER-2 immunohistochemistry in breast carcinoma in Austria.

Authors:  A Reiner-Concin; P Regitnig; H P Dinges; G Höfler; S Lax; E Müller-Holzner; P Obrist; M Rudas
Journal:  Pathol Oncol Res       Date:  2008-08-28       Impact factor: 3.201
  8 in total
  1 in total

1.  Accuracy and Reproducibility of HER2 Status in Breast Cancer Using Immunohistochemistry: A Quality Control Study in Tuscany Evaluating the Impact of Updated 2013 ASCO/CAP Recommendations.

Authors:  S Bianchi; S Caini; M Paglierani; C Saieva; V Vezzosi; G Baroni; A Simoni; D Palli
Journal:  Pathol Oncol Res       Date:  2014-11-04       Impact factor: 3.201
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.